EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Drug Monitoring in Psychiatry: Enhancing Treatment Precision and Patient Outcomes

Letizia Biso iD, Stefano Aringhieri, Marco Carli iD, Marco Scarselli, Biancamaria Longoni

Pharmaceuticals · 16.05.2024 · 17 (5) · 642

DOI: 10.3390/ph17050642 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 16.05.2024. Verfasst von Letizia Biso und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychiatric disorders often require pharmacological interventions to alleviate symptoms and improve quality of life. However, achieving an optimal therapeutic outcome is challenging due to several factors, including variability in the individual response, inter-individual differences in drug metabolism, and drug interactions in polytherapy. Therapeutic drug monitoring (TDM), by measuring drug concentrations in biological samples, represents a valuable tool to address these challenges, by tailoring medication regimens to each individual. This review analyzes the current landscape of TDM in psychiatric practice, highlighting its significance in optimizing drug dosages, minimizing adverse effects, and improving therapeutic efficacy. The metabolism of psychiatric medications (i.e., mood stabilizers, antipsychotics, antidepressants) often exhibits significant inter-patient variability. TDM can help address this variability by enhancing treatment personalization, facilitating early suboptimal- or toxic-level detection, and allowing for timely interventions to prevent treatment failure or adverse effects. Furthermore, this review briefly discusses technological advancements and analytical methods supporting the implementation of TDM in psychiatric settings. These innovations enable quick and cost-effective drug concentration measurements, fostering the widespread adoption of TDM as a routine practice in psychiatric care. In conclusion, the integration of TDM in psychiatry can improve treatment outcomes by individualizing medication regimens within the so-called precision medicine.

Schlagwörter

Stichwörter der Autor:innen

mood stabilizerspsychiatric disorderstherapeutic drug monitoring

Autor:innen und Institutionen

  • Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
  • Mental Health and Pathological Addiction Department, AUSL Romagna Forlì-Cesena, 47121 Forlì, Italy.

ORCID-Profile: Letizia Biso, Marco Carli

Zitieren

APA

Biso, L., Aringhieri, S., Carli, M., Scarselli, M., & Longoni, B. (2024). Therapeutic Drug Monitoring in Psychiatry: Enhancing Treatment Precision and Patient Outcomes. Pharmaceuticals, 17(5), 642. https://doi.org/10.3390/ph17050642

Vancouver

Biso L, Aringhieri S, Carli M, Scarselli M, Longoni B. Therapeutic Drug Monitoring in Psychiatry: Enhancing Treatment Precision and Patient Outcomes. Pharmaceuticals. 2024;17(5):642. doi:10.3390/ph17050642

BibTeX
@article{Biso2024,
  author = {Biso, Letizia and Aringhieri, Stefano and Carli, Marco and Scarselli, Marco and Longoni, Biancamaria},
  title = {Therapeutic Drug Monitoring in Psychiatry: Enhancing Treatment Precision and Patient Outcomes},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {5},
  pages = {642},
  doi = {10.3390/ph17050642}
}
Kostenlos starten →